Why the study?
Does prostaglandin E1 inhibit platelet aggregation and thrombus formation in vitro and in vivo?
Population
In vitro platelet preparations and in vivo experimental mature rabbits (both sexes, 2-3 kg)
Comparison
Prostaglandin E1 administered in vitro and in vivo vs Control (saline or no PGE1)
Design
Preclinical
Authors
Loading...
PGE1's potent antiplatelet effects fail to curb experimental thrombus in rabbits; hypothesis-generating for in vivo antithrombotic limitations.
Does prostaglandin E1 inhibit platelet aggregation and thrombus formation in vitro and in vivo?
PGE1 is a potent inhibitor of platelet aggregation in vitro and in vivo, though its rapid in vivo degradation may limit its efficacy in preventing experimental thrombus formation.
Norio Kobayashi (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: